Latest astrocytoma Stories
A clinical trial has shown that a form of gene therapy is safe for treating a deadly form of brain cancer, even when combined with radiation therapy.
Johns Hopkins researchers have found a likely explanation for the slow growth of the most common childhood brain tumor, pilocytic astrocytoma.
Brain cancer patients who are able to exercise live significantly longer than sedentary patients, according to this study.
CHICAGO, June 6, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
Researchers have found that a synthetic version of hypericin, a compound naturally found in St. John's wort, may be a promising treatment for patients with recurrent malignant brain tumors.
SARASOTA, Fla., April 7, 2011 /PRNewswire/ -- Linda Roberts was puzzled when her favorite food, chocolate ice cream, suddenly did not taste good, and her prized orchids didn't smell nice either.
Pilocytic astrocytoma, the most common brain tumor in children, is usually slow-growing and benign.
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor, and there are few medical therapies available to those patients for whom surgery is not curative.
A detailed analysis of gene fusions present at high frequency in the most common pediatric brain tumors has been performed for the first time.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer.
- Withering but not falling off, as a blossom that persists on a twig after flowering.